Epidural Steroid Injection Risks May Outweigh Benefits: Study

|

A new study suggests that epidural steroid injections do little to alleviate the back pain they are supposed to address, raising questions about the widespread use of the pain management treatment. 

Researchers from the Rothman Institute in Philadelphia published a study last month in the medical journal Spine, which looked at the effectiveness of epidural steroid injections and found that patients who were given the shots to manage pain from a pinched nerve actually showed less improvement than those who did not get the shot.

The researchers looked at 276 patients who suffered from a pinched spinal nerve, also known as a lumbar stenosis. They found that over four years there was less improvement in physical function and reduction of pain, and 58% of those who received epidural steroid injections later opted for surgical treatment. In addition, those who received the injections stayed nearly a day longer in the hospital on average than those who did not get the shots.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

In their conclusion, the researchers theorize that the additional volume added to the body by the fluid in the injection may actually exacerbate the pinched nerve and cause more pain after the short-term pain relieve is gone. The shots may also cause long-term damage to the nerve roots. Researchers called for further investigations into the biological effects of epidural steroid injections.

The study comes on the heels of a nationwide fungal meningitis outbreak that was linked to epidural steroid injections, which were distributed by a now-defunct Massachusetts compounding pharmacy, the New England Compounding Center. The injections were used at hospitals and pain management centers nationwide for back pain treatments, but many were contaminated with fungus, resulting in an outbreak that sickened about 700 people across the country and led to 48 deaths.

NECC faces a growing number of fungal meningitis lawsuits following the outbreak, and declared bankruptcy late last year under the weight of the oncoming litigation. The owners may also face state and federal criminal charges. The outbreak has also led to increased crackdowns on compounding pharmacies by state and federal agencies nationwide.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.
An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe.